@inproceedings{36b9bd449a484200b891b8db3df9fbf4,
title = "The impact of regenerative therapies in the clinic with supporting evidence from the lab",
abstract = "Statement of Purpose: Axolotl Biologix is a regenerative medicine company that produces a stem cell-derived regenerative fluid (Axolotl Ambient{\texttrademark}) and an amniotic membrane (Axolotl DualGraft{\texttrademark}) that are used to promote wound healing and joint repair. In vitro bioassays are used to gain an understanding of the cellular processes that produce the clinical observations.",
author = "Audet, {Robert G.} and Diller, {Robert B.} and Dominic Dominguez and Kellar, {Robert S}",
note = "Publisher Copyright: {\textcopyright} 2019 Omnipress - All rights reserved.; 42nd Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence ; Conference date: 03-04-2019 Through 06-04-2019",
year = "2019",
language = "English (US)",
series = "Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium",
publisher = "Society for Biomaterials",
pages = "171",
booktitle = "Society for Biomaterials Annual Meeting and Exposition 2019",
}